Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» pemvidutide
pemvidutide
Altimmune to test obesity drug for alcohol use disorder and related health conditions
MSN/Reuters
Fri, 03/14/25 - 11:40 am
Altimmune
obesity
pemvidutide
alcohol use disorder
If These 3 Words Are True, Altimmune's Weight Loss Candidate Could Beat Novo Nordisk's Wegovy
Motley Fool
Sun, 06/30/24 - 09:56 pm
Altimmune
Novo Nordisk
Wegovy
weight loss
pemvidutide
Altimmune Targets Obesity Market With Weight-Loss Drug That Preserves Lean Muscle Mass
BioSpace
Mon, 06/24/24 - 10:18 pm
Altimmune
pemvidutide
weight loss
clinical trials
obesity
Altimmune Joins Weight-Loss Race with Phase II Win, Stock Jumps on News
BioSpace
Fri, 12/1/23 - 09:46 am
Altimmune
clinical trials
obesity
GLP-1 agonist
pemvidutide
Altimmune completes dosing in MOMENTUM trial to treat obesity
Clinical Trials Arena
Wed, 09/13/23 - 11:15 am
Altimmune
clinical trials
pemvidutide
obesity
Altimmune sees phase 1 success in tricky NASH indication with GLP-1 agonist
Fierce Biotech
Wed, 09/14/22 - 08:06 pm
Altimmune
NASH
clinical trials
pemvidutide
Altimmune slips after posting 12-week data from Phase 1 trial for weight loss therapy
Seeking Alpha
Tue, 09/28/21 - 11:14 pm
Altimmune
clinical trials
obesity
pemvidutide